Pieffer over at CYP has some interesting information in his posts if you want to delve into the science and the collected argument.
Re "CYP say that they only need 2 doses of their stem cells to get the same result with aGVHD", you'll find the enrolled people were sicker in MSB cohort, not to mention one study was for adult and one was for children. Small study, hardly comparable. When your starved for information, we try to compare the incomparable. That's human nature, It the wild claims that are dangerous for investors.
It has promise, I recall SI saying, he looked at it and seen no real advantage. He obliviously chose to back another horse.
If MSB does well i'm sure others in the space will get a leg up.
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-3494
-
- There are more pages in this discussion • 14,542 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
93.5¢ |
Change
0.020(2.19%) |
Mkt cap ! $1.067B |
Open | High | Low | Value | Volume |
92.0¢ | 94.5¢ | 92.0¢ | $1.622M | 1.742M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 64563 | 93.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
94.0¢ | 204239 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 64563 | 0.930 |
6 | 79973 | 0.925 |
13 | 254982 | 0.920 |
11 | 107275 | 0.915 |
4 | 115328 | 0.910 |
Price($) | Vol. | No. |
---|---|---|
0.940 | 204239 | 3 |
0.945 | 22942 | 2 |
0.950 | 91123 | 5 |
0.955 | 42425 | 1 |
0.960 | 61820 | 3 |
Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |